Literature DB >> 20079678

Polymeric particles in vaccine delivery.

Allison C Rice-Ficht1, Angela M Arenas-Gamboa, Melissa M Kahl-McDonagh, Thomas A Ficht.   

Abstract

The tremendous power of the particulate vaccine delivery system has only recently been recognized and employed strategically in vaccine design. The entrapment of antigen in particles clearly alters its acquisition and processing by antigen presenting cells and ensuing adaptive immunity. The adjuvant activity of particles has recently been described at the molecular level as engaging the Nalp3 inflammasome and complementing the activity of toll-like receptor ligands. The inclusion of antigen within erodible particles and subsequent delivery to dendritic cells (DCs), enables antigen-specific cell-mediated immunity and extended antigen presentation with protective outcomes. Particles less than 1 microm in size with amphipathic coatings efficiently deliver antigen to and activate DCs with concomitant engagement of humoral and cellular immunity. The size and dissolution rates of particles as well as surface chemistry and charge appear to be central in tuning adaptive immunity. Copyright 2010. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20079678     DOI: 10.1016/j.mib.2009.12.001

Source DB:  PubMed          Journal:  Curr Opin Microbiol        ISSN: 1369-5274            Impact factor:   7.934


  45 in total

1.  Vaccines displaying mycobacterial proteins on biopolyester beads stimulate cellular immunity and induce protection against tuberculosis.

Authors:  Natalie A Parlane; Katrin Grage; Jun Mifune; Randall J Basaraba; D Neil Wedlock; Bernd H A Rehm; Bryce M Buddle
Journal:  Clin Vaccine Immunol       Date:  2011-11-09

2.  Engineering bacteria to manufacture functionalized polyester beads.

Authors:  Jenny L Draper; Bernd H Rehm
Journal:  Bioengineered       Date:  2012-06-18       Impact factor: 3.269

3.  Analyzing cellular internalization of nanoparticles and bacteria by multi-spectral imaging flow cytometry.

Authors:  Yashdeep Phanse; Amanda E Ramer-Tait; Sherree L Friend; Brenda Carrillo-Conde; Paul Lueth; Carrie J Oster; Gregory J Phillips; Balaji Narasimhan; Michael J Wannemuehler; Bryan H Bellaire
Journal:  J Vis Exp       Date:  2012-06-08       Impact factor: 1.355

Review 4.  Drug targeting to infectious diseases by nanoparticles surface functionalized with special biomolecules.

Authors:  Shyam Sundar; Vijay Kumar Prajapati
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

5.  Protective antibody response following oral vaccination with microencapsulated Bacillus Anthracis Sterne strain 34F2 spores.

Authors:  Jamie Benn Felix; Sankar P Chaki; Yi Xu; Thomas A Ficht; Allison C Rice-Ficht; Walter E Cook
Journal:  NPJ Vaccines       Date:  2020-07-10       Impact factor: 7.344

Review 6.  Nanocarriers targeting dendritic cells for pulmonary vaccine delivery.

Authors:  Nitesh K Kunda; Satyanarayana Somavarapu; Stephen B Gordon; Gillian A Hutcheon; Imran Y Saleem
Journal:  Pharm Res       Date:  2012-10-09       Impact factor: 4.200

7.  Rapid and Persistent Delivery of Antigen by Lymph Node Targeting PRINT Nanoparticle Vaccine Carrier To Promote Humoral Immunity.

Authors:  Sarah N Mueller; Shaomin Tian; Joseph M DeSimone
Journal:  Mol Pharm       Date:  2015-04-08       Impact factor: 4.939

Review 8.  Tumor lysate-loaded biodegradable microparticles as cancer vaccines.

Authors:  Vijaya B Joshi; Sean M Geary; Brett P Gross; Amaraporn Wongrakpanich; Lyse A Norian; Aliasger K Salem
Journal:  Expert Rev Vaccines       Date:  2014-01       Impact factor: 5.217

9.  Oral Biologic Delivery: Advances Toward Oral Subunit, DNA, and mRNA Vaccines and the Potential for Mass Vaccination During Pandemics.

Authors:  Jacob William Coffey; Gaurav Das Gaiha; Giovanni Traverso
Journal:  Annu Rev Pharmacol Toxicol       Date:  2020-08-31       Impact factor: 13.820

10.  Spray-dried chitosan microparticles for cellular delivery of an antigenic protein: physico-chemical properties and cellular uptake by dendritic cells and macrophages.

Authors:  Chirasak Kusonwiriyawong; Vimolmas Lipipun; Nontima Vardhanabhuti; Qiang Zhang; Garnpimol C Ritthidej
Journal:  Pharm Res       Date:  2013-03-13       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.